A detailed history of Quarry LP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Quarry LP holds 7,500 shares of ROIV stock, worth $84,000. This represents 0.02% of its overall portfolio holdings.

Number of Shares
7,500
Previous 5,000 50.0%
Holding current value
$84,000
Previous $52.9 Million 63.77%
% of portfolio
0.02%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.17 - $12.5 $25,425 - $31,250
2,500 Added 50.0%
7,500 $86.6 Million
Q2 2024

Aug 14, 2024

BUY
$10.36 - $11.74 $51,800 - $58,700
5,000 New
5,000 $52.9 Million

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $7.89B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Quarry LP Portfolio

Follow Quarry LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quarry LP, based on Form 13F filings with the SEC.

News

Stay updated on Quarry LP with notifications on news.